Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection.
Kovacs
J A
JA
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892-1662, USA.
Masur
H
H
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control*; D019072:Antibiotic Prophylaxis; D000995:Antitubercular Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D018890:Chemoprevention; D004347:Drug Interactions; D015774:Ganciclovir / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D017410:Practice Guidelines as Topic; D055502:Secondary Prevention; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000995:Antitubercular Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015774:Ganciclovir